References
- AikawaMLibbyPThe vulnerable atherosclerotic plaque: pathogenesis and therapeutic approachCardiovasc Pathol200413312513815081469
- LibbyPAikawaMStabilization of atherosclerotic plaques: new mechanisms and clinical targetsNat Med20028111257126212411953
- ShahPKMechanisms of plaque vulnerability and ruptureJ Am Coll Cardiol2003414 Suppl S15S22S12644336
- VirmaniRBurkeAPFarbAKolodgieFDPathology of the vulnerable plaqueJ Am Coll Cardiol200647Suppl 8C13C1816631505
- RuehmSGCorotCVogtPKolbSDebatinJFMagnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbitsCirculation2001103341542211157694
- TrivediRAMallawarachiCU-King-ImJMIdentifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophagesArterioscler Thromb Vasc Biol20062671601160616627809
- KooiMECappendijkVCCleutjensKBAccumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imagingCirculation2003107192453245812719280
- MorishigeKKacherDFLibbyPHigh-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosisCirculation2010122171707171520937980
- WeisslederRElizondoGWittenbergJUltrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imagingRadiology199017524894932326474
- VassalloPMateiCHestonWDAMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodesRadiology199419325015067972768
- WeinmannHJEbertWMisselwitzBSchmitt-WillichHTissue-specific MR contrast agentsEur J Radiol2003461334412648800
- ChoWSChoMKimSRPulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imagingToxicol Appl Pharmacol2009239110611519520096
- SchulzeEFerrucciJTPossKLapointeLBogdanovaAWeisslederRCellular uptake and trafficking of a prototypical magnetic iron oxide label in vitroInvest Radiol199530106046108557500
- WeisslederRStarkDDEngelstadBLSuperparamagnetic iron oxide: pharmacokinetics and toxicityAJR Am J Roentgenol198915211671732783272
- YungCWFieringJMuellerAJIngberDEMicromagnetic-microfluidic blood cleansing deviceLab Chip2009991171117719370233
- ChenHEbnerADRitterJAKaminskeMDRosengartAJTheoretical Analysis of a Magnetic Separator Device for Ex-Vivo Blood DetoxificationSep Sci Technol20084359961020
- StamopoulosDBenakiDBouziotisPZirogiannisPNIn vitro utilization of ferromagnetic nanoparticles in hemodialysis therapyNanotechnology2007184949510220442466
- StamopoulosDBouziotisPBenakiDKotsovassilisCZirogiannisPNUtilization of nanobiotechnology in haemodialysis: mock-dialysis experiments on homocysteineNephrol Dial Transplant200823103234323918398014
- StamopoulosDBouziotisPBenakiDNanobiotechnology for the prevention of dialysis-related amyloidosisTher Apher Dial2009131344119379168
- StamopoulosDManiosEGogolaVBare and protein-conjugated Fe(3)O(4) ferromagnetic nanoparticles for utilization in magnetically assisted hemodialysis: biocompatibility with human blood cellsNanotechnology2008195050510119942758
- YallapuMMOthmanSFCurtisETGuptaBKJaggiMChauhanSCMulti-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapyBiomaterials20113271890190521167595
- ThiesenBJordanAClinical applications of magnetic nanoparticles for hyperthermiaInt J Hyperthermia200824646747418608593
- RabiasITsitrouliDKarakostaERapid magnetic heating treatment by highly charged maghemite nanoparticles on Wistar rats exocranial glioma tumors at microliter volumeBiomicrofluidics20104202411120697578
- HayashiKOnoKSuzukiHHigh-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effectACS Appl Mater Interfaces2010271903191120568697
- SonodaANittaNNitta-SekoAComplex comprised of dextran magnetite and conjugated cisplatin exhibiting selective hyperthermic and controlled-release potentialInt J Nanomedicine2010549950420957172
- BouhlelMADerudasBRigamontiEPPARgamma activation primes human monocytes into alternative M2 macrophages with antiinflammatory propertiesCell Metab20076213714317681149
- KoppAFLaniadoMDammannFMR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic propertiesRadiology199720437497569280254
- Zimmermann-PaulGGQuickHHVogtPHigh-resolution intravascular magnetic resonance imaging: monitoring of plaque formation in heritable hyperlipidemic rabbitsCirculation19999981054106110051300
- BanerjeeSNarayananKMizutaniTMakinoSMurine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cellsJ Virol200276125937594812021326
- KhouryMEscriouVCourtiesGEfficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexesArthritis Rheum20085882356236718668557
- TaniguchiSYanaseTKobayashiKTakayanagiRNawataHDehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cellsAtherosclerosis199612611431548879442
- JoJAokiITabataYDesign of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cellsJ Control Release2010142346547319932720
- RoznemanYZouXMKantorHLSignal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images: the role of diffusionMagn Reson Med199014131392352471
- WijagkanalanWHiguchiYKawakamiSEnhanced antiinflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation modelMol Pharmacol20087451183119218669445
- KuramotoYKawakamiSZhouSUse of mannosylated cationic liposomes/immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in miceJ Gene Med200810439239918181219
- WijagkanalanWKawakamiSTakenagaMEfficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in ratsJ Control Release2008125212113018037185
- RossRAtherosclerosis is an inflammatory diseaseAm Heart J19991385 Pt 2S419S42010539839
- EsperEChanEKBuchwaldHNatural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. I. The effects of aging and gender on plasma lipids and lipoproteinsJ Lab Clin Med19931211971028426086
- EsperERungeWJGuntherRBuchwaldHNatural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring aortic and coronary lesionsJ Lab Clin Med199312111031108426070
- DonnellyTMKelseySFLevineDMParkerTSControl of variance in experimental studies of hyperlipidemia using the WHHL rabbitJ Lipid Res1991327108910981940633
- AtkinsonJBHooverRLBerryKKSwiftLLCholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: A new model for atherosclerosisAtherosclerosis1989782–31231362783197